Κατευθυντήριες Οδηγίες

Καντιντιάσεις

  1. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.
  2. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT).
  3. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.
  4. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: patients with HIV infection or AIDS.
  5. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures.
  6. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases.
  7. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp.
  8. Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).
  9. Erratum in: Mycoses. 2015 May;58(5):324. Multiple author names added.

Κρυπτοκόκκωση
Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.

Ασπεργίλλωση

  1. Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.
  2. Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management.
  3. Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation.

 

Μουκορμύκωση

  1. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013.
  2. Diagnosis and treatment of mucormycosis in patients with hematological malignancies:guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3).

 

Σπάνιες συστηματικές μυκητιάσεις

  1. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections.
  2. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi.
  3. ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others.

 

Ενδημικές μυκητιάσεις

  1. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America.
  2. Clinical practice guidelines for the management of sporotrichosis: 2007 update by the Infectious Diseases Society of America.
  3. Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America.
  4. 2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis.

 

Ονυχομυκητίαση

British Association of Dermatologists’ guidelines for the management of onychomycosis 2014.

 

Γενικά

  1. ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients.
  2. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America.
  3. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.
  4. Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria.